Luo, Libo
Jiang, Minlin
Wu, Hong
Liu, Yiqiang
Wang, Haowei
Zhou, Caicun
Ren, Shengxiang
Chen, Xiaoxia
Jiang, Tao
Xu, Chuan
Funding for this research was provided by:
Shanghai Nature Foundation Project (21ZR1453200)
National Natural Science Foundation of China (82102859, 92259102)
Shanghai Rising-Star Program (23QA1408000)
Shanghai Science and Technology Innovation Action Plan Medical Innovation Research Program (21Y11913600 and 23Y11904100)
the National Key Research and Development Program of China (2023YFC3402100)
Article History
Received: 21 March 2024
Accepted: 15 May 2024
First Online: 4 June 2024
Declarations
:
: Caicun Zhou reported honoraria as a speaker from Roche, Lily China, Boehringer Ingelheim, Merck, Hengrui, Qilu, Sanofi, Merck Sharp & Dohme, Innovent Biologics, C-Stone, Luye Pharma, TopAlliance Biosciences, and Amoy Diagnostics; and advisor fees for Innovent Biologics, Hengrui, Qilu, and TopAlliance Biosciences. The other authors declare no potential conflict of interest.
: This study was performed in line with the principles of the Declaration of Helsinki. Ethics approval was not required.
: Informed consent was waived for retrospective studies. All patient information was deidentified prior to data analysis.
: Not applicable.